LABCORP HOLDINGS INC (LH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LH | Director | ["Rheumatologist and molecular immunologist","Former Dean of the Medical Faculty for Johns Hopkins University School of Medicine","CEO of Johns Hopkins Medicine","Leadership positions at Columbia University and the University of Iowa","Bachelor of Science in Biology from the Massachusetts Institute of Technology","Doctor of Medicine from Yale University","Extensive expertise in patient care, science, and medicine relevant to the clinical laboratory business","Operational, management, and executive leadership experience","Deep understanding of the complexity of the U.S. healthcare delivery system and policy development"] | ["Quality and Compliance Committee","Compensation and Human Capital Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Paul B. Rothman has served as a director of the Company and member of the Quality and Compliance Committee since June 2023. He has served as the Chair of the Quality and Compliance Committee since June 2024. Dr. Rothman, a rheumatologist and molecular immunologist, was previously the Dean of the Medical Faculty for Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, during which time he oversaw both the Johns Hopkins Health System and the School of Medicine. Prior to serving at Johns Hopkins, Dr. Rothman held various leadership positions at Columbia University and the University of Iowa. Dr. Rothman holds a Bachelor of Science in Biology from the Massachusetts Institute of Technology and a Doctor of Medicine from Yale University.